Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipomatous hamartoma of the semilunar valve exhibits molecular genetic characteristics of lipoma.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same author

Impact of time-of-day on immune checkpoint inhibitor therapy in cancer patients: an up-to-date clinical review.

Frontiers in immunology·2026
Same author

Zinner Syndrome: A Narrative Review of Imaging Findings with an Illustrative Case Report.

Diagnostics (Basel, Switzerland)·2026
Same author

Non-Infectious Causes for Elevated Procalcitonin.

Medicina (Kaunas, Lithuania)·2026
Same author

MRI-Based Differentiation of Tumor Deposits and Lymph Node Metastases in Rectal Cancer: A Systematic Review of Diagnostic Performance.

Journal of clinical medicine·2026
Same author

Baseline and Dynamic Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Metastatic Colorectal Cancer Patients Treated with Panitumumab.

Journal of personalized medicine·2026

Related Experiment Video

Updated: Jun 1, 2025

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.1K

Macrotrabecular-Massive Hepatocellular Carcinoma: A Case Report.

Raphaël Eftimie Spitz1, Simona Manole2, Teodora Surdea-Blaga3

  • 1Department of Clinical Immunology and Allergology, Iuliu Hatieganu University of Medicine and Pharmacy of Cluj, Cluj-Napoca, ROU.

Cureus
|January 21, 2025
PubMed
Summary

Macrotrabecular-massive hepatocellular carcinoma (MTM-HCC), an aggressive liver cancer subtype, presents unique challenges due to its occurrence in non-cirrhotic livers and poor response to standard treatments. This case highlights the urgent need for novel therapeutic strategies for MTM-HCC.

Keywords:
abdominal ct scansartificial intelligencecase reportchest ct scanhbv infectionhepatocarcinomaimmunotherapymacrotrabecular-massive hepatocellular carcinomamripet-ct scan

More Related Videos

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

3.2K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.2K

Related Experiment Videos

Last Updated: Jun 1, 2025

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.1K
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

3.2K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.2K

Area of Science:

  • Hepatology
  • Oncology
  • Molecular Pathology

Background:

  • Macrotrabecular-massive hepatocellular carcinoma (MTM-HCC) is a rare, aggressive subtype of liver cancer.
  • Unlike typical HCC, MTM-HCC can occur in non-cirrhotic livers, posing diagnostic and therapeutic challenges.

Observation:

  • A 35-year-old male presented with epigastric pain, fatigue, and hepatomegaly.
  • Imaging revealed a large hepatic mass with portal vein thrombosis and metastases.
  • Histopathology confirmed MTM-HCC.

Findings:

  • The patient received standard treatment for advanced HCC (immune checkpoint inhibitors and anti-angiogenic agents).
  • Disease progression occurred after four cycles, leading to a rapid decline and death.
  • MTM-HCC exhibits distinct molecular and histological features contributing to its aggressive nature and poor prognosis.

Implications:

  • This case underscores the aggressive behavior and limited treatment responsiveness of MTM-HCC.
  • Heightened clinical vigilance is crucial for early detection, especially in younger patients with atypical liver disease symptoms.
  • Developing targeted therapies and further research into MTM-HCC molecular characteristics are essential for improving patient outcomes.